179 related articles for article (PubMed ID: 36934643)
1. Superspreading potentials of SARS-CoV-2 Delta variants across different contact settings in Eastern China: A retrospective observational study.
Wang K; Luan Z; Guo Z; Lei H; Zeng T; Yu L; Li H; Tian M; Ran J; Zhao S
J Infect Public Health; 2023 May; 16(5):689-696. PubMed ID: 36934643
[TBL] [Abstract][Full Text] [Related]
2. Case clustering, contact stratification, and transmission heterogeneity of SARS-CoV-2 Omicron BA.5 variants in Urumqi, China: An observational study.
Lu Y; Guo Z; Zeng T; Sun S; Lu Y; Teng Z; Tian M; Wang J; Li S; Fan X; Luan Z; Wang W; Cai Y; Wang K; Zhao S
J Glob Health; 2023 May; 13():06018. PubMed ID: 37199483
[TBL] [Abstract][Full Text] [Related]
3. Differences in the superspreading potentials of COVID-19 across contact settings.
Zhao Y; Zhao S; Guo Z; Yuan Z; Ran J; Wu L; Yu L; Li H; Shi Y; He D
BMC Infect Dis; 2022 Dec; 22(1):936. PubMed ID: 36510138
[TBL] [Abstract][Full Text] [Related]
4. The Association Between Clinical Severity and Incubation Period of SARS-CoV-2 Delta Variants: Retrospective Observational Study.
Wang K; Luan Z; Guo Z; Ran J; Tian M; Zhao S
JMIR Public Health Surveill; 2022 Nov; 8(11):e40751. PubMed ID: 36346940
[TBL] [Abstract][Full Text] [Related]
5. Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2.
Kuylen EJ; Torneri A; Willem L; Libin PJK; Abrams S; Coletti P; Franco N; Verelst F; Beutels P; Liesenborgs J; Hens N
PLoS Comput Biol; 2022 Aug; 18(8):e1009980. PubMed ID: 35994497
[TBL] [Abstract][Full Text] [Related]
6. Transmission Characteristics and Inactivated Vaccine Effectiveness Against Transmission of SARS-CoV-2 Omicron BA.5 Variants in Urumqi, China.
Wang K; Guo Z; Zeng T; Sun S; Lu Y; Wang J; Li S; Luan Z; Li H; Zhang J; Wang Y; Lu Y; Zhao S
JAMA Netw Open; 2023 Mar; 6(3):e235755. PubMed ID: 36995713
[TBL] [Abstract][Full Text] [Related]
7. Transmission Dynamics of the Delta Variant of SARS-CoV-2 Infections in South Korea.
Hwang H; Lim JS; Song SA; Achangwa C; Sim W; Kim G; Ryu S
J Infect Dis; 2022 Mar; 225(5):793-799. PubMed ID: 34865022
[TBL] [Abstract][Full Text] [Related]
8. Superspreading, overdispersion and their implications in the SARS-CoV-2 (COVID-19) pandemic: a systematic review and meta-analysis of the literature.
Wegehaupt O; Endo A; Vassall A
BMC Public Health; 2023 May; 23(1):1003. PubMed ID: 37254143
[TBL] [Abstract][Full Text] [Related]
9. Comparison of epidemiological characteristics and transmissibility of different strains of COVID-19 based on the incidence data of all local outbreaks in China as of March 1, 2022.
Niu Y; Luo L; Yang S; Abudurusuli G; Wang X; Zhao Z; Rui J; Li Z; Deng B; Liu W; Zhang Z; Li K; Liu C; Li P; Huang J; Yang T; Wang Y; Chen T; Li Q
Front Public Health; 2022; 10():949594. PubMed ID: 36187650
[TBL] [Abstract][Full Text] [Related]
10. A statistical framework for tracking the time-varying superspreading potential of COVID-19 epidemic.
Guo Z; Zhao S; Lee SS; Hung CT; Wong NS; Chow TY; Yam CHK; Wang MH; Wang J; Chong KC; Yeoh EK
Epidemics; 2023 Mar; 42():100670. PubMed ID: 36709540
[TBL] [Abstract][Full Text] [Related]
11. Comparing the incubation period, serial interval, and infectiousness profile between SARS-CoV-2 Omicron and Delta variants.
Guo Z; Zhao S; Mok CKP; So RTY; Yam CHK; Chow TY; Chan TCP; Wei Y; Jia KM; Wang MH; Chong KC; Yeoh EK
J Med Virol; 2023 Mar; 95(3):e28648. PubMed ID: 36892159
[TBL] [Abstract][Full Text] [Related]
12. Variability in transmission risk of SARS-CoV-2 in close contact settings: A contact tracing study in Shandong Province, China.
Tsang TK; Fang LQ; Zhang A; Jiang FC; Ruan SM; Liu LZ; Cowling BJ; Liu W; Yang Y
Epidemics; 2022 Jun; 39():100553. PubMed ID: 35287110
[TBL] [Abstract][Full Text] [Related]
13. Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants.
Trobajo-Sanmartín C; Martínez-Baz I; Miqueleiz A; Fernández-Huerta M; Burgui C; Casado I; Baigorría F; Navascués A; Castilla J; Ezpeleta C
Microbiol Spectr; 2022 Apr; 10(2):e0000822. PubMed ID: 35412379
[TBL] [Abstract][Full Text] [Related]
14. Systematic review and meta-analyses of superspreading of SARS-CoV-2 infections.
Du Z; Wang C; Liu C; Bai Y; Pei S; Adam DC; Wang L; Wu P; Lau EHY; Cowling BJ
Transbound Emerg Dis; 2022 Sep; 69(5):e3007-e3014. PubMed ID: 35799321
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Unlinked Cases of COVID-19 and Implications for Contact Tracing Measures: Retrospective Analysis of Surveillance Data.
Chong KC; Jia K; Lee SS; Hung CT; Wong NS; Lai FTT; Chau N; Yam CHK; Chow TY; Wei Y; Guo Z; Yeoh EK
JMIR Public Health Surveill; 2021 Nov; 7(11):e30968. PubMed ID: 34591778
[TBL] [Abstract][Full Text] [Related]
16. Dining-Out Behavior as a Proxy for the Superspreading Potential of SARS-CoV-2 Infections: Modeling Analysis.
Chong KC; Li K; Guo Z; Jia KM; Leung EYM; Zhao S; Hung CT; Yam CHK; Chow TY; Dong D; Wang H; Wei Y; Yeoh EK
JMIR Public Health Surveill; 2023 Mar; 9():e44251. PubMed ID: 36811849
[TBL] [Abstract][Full Text] [Related]
17. New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach.
Yen AM; Chen TH; Chang WJ; Lin TY; Jen GH; Hsu CY; Wang ST; Dang H; Chen SL
JMIR Public Health Surveill; 2022 Nov; 8(11):e40866. PubMed ID: 36265134
[TBL] [Abstract][Full Text] [Related]
18. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
[TBL] [Abstract][Full Text] [Related]
19. Superspreading events of SARS-CoV-2 in Paris: A retrospective analysis of data from the first wave of COVID-19 in 2020.
Deslandes A; Calba C; Mahdjoub S; Zhu-Soubise A; Mathey D; Ardoin A
J Infect Public Health; 2021 Nov; 14(11):1733-1738. PubMed ID: 34715427
[TBL] [Abstract][Full Text] [Related]
20. Superspreading potential of SARS-CoV-2 Delta variants under intensive disease control measures in China.
Zhao S; Guo Z; Chong MKC; He D; Wang MH
J Travel Med; 2022 May; 29(3):. PubMed ID: 35238919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
